Reducing Opioid Overprescribing through Procedure-specific Prescribing Guidelines.
Publication/Presentation Date
1-1-2023
Abstract
UNLABELLED: Despite advances in opioid-sparing pain management, postdischarge opioid overprescribing in plastic surgery remains an issue. Procedure-specific prescribing protocols have been implemented successfully in other surgical specialties but not broadly in plastic surgery. This study examined the efficacy of procedure-specific prescribing guidelines for reducing postdischarge opioid overprescribing.
METHODS: A total of 561 plastic surgery patients were evaluated retrospectively after a prescribing guideline, which recommended postdischarge prescription amounts based on the type of operation, was introduced in July 2020. Prescription and postdischarge opioid consumption amounts before (n = 428) and after (n = 133) guideline implementation were compared. Patient satisfaction and prescription frequency of nonopioid analgesia were also compared.
RESULTS: The average number of opioid pills per prescription decreased by 25% from 19.3 (27.4 OME) to 15.0 (22.7 OME;
CONCLUSIONS: A procedure-specific prescribing model is a straight-forward intervention to promote safer opioid-prescribing practices in plastic surgery. Its usage in clinical practice may lead to more appropriate opioid prescribing.
Volume
11
Issue
1
First Page
4776
Last Page
4776
ISSN
2169-7574
Published In/Presented At
Zhang, K. K., Blum, K. M., Chu, J. J., Sharma, S., Skoracki, R. J., Moore, A. M., Janis, J. E., & Barker, J. C. (2023). Reducing Opioid Overprescribing through Procedure-specific Prescribing Guidelines. Plastic and reconstructive surgery. Global open, 11(1), e4776. https://doi.org/10.1097/GOX.0000000000004776
Disciplines
Medicine and Health Sciences
PubMedID
36699205
Department(s)
Fellows and Residents
Document Type
Article